| Nome |
# |
|
Role of perfusion machines in the setting of clinical liver transplantation. A qualitative systematic review, file e383531a-c575-15e8-e053-a505fe0a3de9
|
244
|
|
Platelet-to-lymphocyte ratio in the setting of liver transplantation for hepatocellular cancer. A systematic review and meta-analysis, file e383531a-a4d0-15e8-e053-a505fe0a3de9
|
232
|
|
Donor-to-recipient gender match in liver transplantation. A systematic review and meta-analysis, file e383531a-a4be-15e8-e053-a505fe0a3de9
|
200
|
|
The effect of 12 weeks of β-hydroxy-β-methyl-butyrate supplementation after liver transplantation. A pilot randomized controlled study, file e3835324-601b-15e8-e053-a505fe0a3de9
|
182
|
|
Microbial translocation and T cell activation are modified by direct-acting antiviral therapy in HCV-infected patients, file e383531e-cbd3-15e8-e053-a505fe0a3de9
|
172
|
|
Metabolic syndrome and cardiovascular risk after liver transplantation: a single-center experience., file e3835322-5326-15e8-e053-a505fe0a3de9
|
149
|
|
Progenitor cell niches in the human pancreatic duct system and associated pancreatic duct glands: an anatomical and immunophenotyping study, file e3835314-24f6-15e8-e053-a505fe0a3de9
|
139
|
|
Peribiliary glands as a niche of extra-pancreatic precursors yielding insulin-producing cells in experimental and human diabetes, file e3835314-8c05-15e8-e053-a505fe0a3de9
|
122
|
|
Imaging follow-up after liver transplantation, file e3835322-e137-15e8-e053-a505fe0a3de9
|
119
|
|
Donor small-droplet macrovesicular steatosis affects liver transplant outcome in HCV-negative recipients, file e3835322-2d81-15e8-e053-a505fe0a3de9
|
109
|
|
Transplantation of human fetal biliary tree stem/progenitor cells into two patients with advanced liver cirrhosis., file e3835312-62c5-15e8-e053-a505fe0a3de9
|
104
|
|
Fluctuations of estimated glomerular filtration rate outside kidney disease improving global outcomes diagnostic criteria for acute kidney injury in end-stage liver disease outpatients and outcome postliver transplantation, file e3835319-b183-15e8-e053-a505fe0a3de9
|
102
|
|
Laparoscopy in liver transplantation: The future has arrived, file e3835322-5324-15e8-e053-a505fe0a3de9
|
87
|
|
Matrisome analysis of intrahepatic cholangiocarcinoma unveils a peculiar cancer-associated extracellular matrix structure, file e3835323-a5ac-15e8-e053-a505fe0a3de9
|
86
|
|
Weight gain and de novo metabolic disorders after liver transplantation, file e3835324-6015-15e8-e053-a505fe0a3de9
|
84
|
|
Adrenocortical carcinoma with inferior vena cava, left renal vein and right atrium tumor thrombus extension, file e3835320-e0ac-15e8-e053-a505fe0a3de9
|
81
|
|
ETHICAL CONSIDERATIONS ON KIDNEY TRANSPLANTATION FROM LIVING DONORS, file e3835311-77bb-15e8-e053-a505fe0a3de9
|
72
|
|
Platelets and hepatocellular cancer: Bridging the bench to the clinics, file e3835323-bc6f-15e8-e053-a505fe0a3de9
|
65
|
|
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis., file e3835311-869a-15e8-e053-a505fe0a3de9
|
60
|
|
Risk of virus and non-virus related malignancies following immunosuppression in a cohort of liver transplant recipients. Italy, 1985–2014, file e383532c-2b8c-15e8-e053-a505fe0a3de9
|
57
|
|
The propensity of the human liver to form large lipid droplets is associated with pnpla3 polymorphism, reduced insig1 and npc1l1 expression and increased fibrogenetic capacity, file e383532c-c99c-15e8-e053-a505fe0a3de9
|
53
|
|
Survival after the diagnosis of de novo malignancy in liver transplant recipients, file e383532b-ec55-15e8-e053-a505fe0a3de9
|
52
|
|
CONUT score predicts early morbidity after liver transplantation: a collaborative study, file e383532d-ccf3-15e8-e053-a505fe0a3de9
|
49
|
|
Identification of an upper limit of tumor burden for downstaging in candidates with hepatocellular cancer waiting for liver transplantation. A west–east collaborative effort, file e3835328-05b0-15e8-e053-a505fe0a3de9
|
47
|
|
Head and neck and esophageal cancers after liver transplant. Results from a multicenter cohort study. Italy, 1997-2010, file e383532c-6981-15e8-e053-a505fe0a3de9
|
46
|
|
The role of the comprehensive complication index for the prediction of survival after liver transplantation, file e3835328-13e3-15e8-e053-a505fe0a3de9
|
45
|
|
SARS-CoV2 and immunosuppression. A double-edged sword, file e3835328-2e41-15e8-e053-a505fe0a3de9
|
45
|
|
Electronic outpatient referral system for liver transplant improves appropriateness and allows first visit triage, file e383532d-6bc9-15e8-e053-a505fe0a3de9
|
44
|
|
Diffusion MRI Findings in Encephalopathy Induced by Immunosuppressive Therapy after Liver Transplantation, file e3835329-24f5-15e8-e053-a505fe0a3de9
|
41
|
|
Low serum magnesium concentration is associated with the presence of viable hepatocellular carcinoma tissue in cirrhotic patients, file e383532c-fe45-15e8-e053-a505fe0a3de9
|
40
|
|
Qualitative analysis of small (≤2 cm) regenerative nodules, dysplastic nodules and well-differentiated HCCs with gadoxetic acid MRI, file e3835320-6077-15e8-e053-a505fe0a3de9
|
37
|
|
Performance of comprehensive complication index and clavien‐dindo complication scoring system in liver surgery for hepatocellular carcinoma, file e3835329-eadd-15e8-e053-a505fe0a3de9
|
35
|
|
Primary anaplastic large T-cell lymphoma of the psoas muscle, file e383532c-0e71-15e8-e053-a505fe0a3de9
|
34
|
|
Increased cancer risk in patients undergoing dialysis: A population-based cohort study in North-Eastern Italy, file e383532c-0ec3-15e8-e053-a505fe0a3de9
|
33
|
|
Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation, file e3835311-b5b9-15e8-e053-a505fe0a3de9
|
30
|
|
Liver Match, a prospective observational cohort study on liver transplantation in Italy: Study design and current practice of donor-recipient matching, file e3835311-e204-15e8-e053-a505fe0a3de9
|
29
|
|
SARS-CoV-2 vaccination with bnt162b2 in renal transplant patients. Risk factors for impaired response and immunological implications, file e383532c-ff56-15e8-e053-a505fe0a3de9
|
27
|
|
Cumulative incidence of solid and hematological De novo malignancy after liver transplantation in a multicentre cohort, file e383532d-3eb4-15e8-e053-a505fe0a3de9
|
25
|
|
Nutritional status: its influence on the outcome of patients undergoing liver transplantation, file e3835311-c637-15e8-e053-a505fe0a3de9
|
18
|
|
RIFLE Criteria and Hepatic Function in the Assessment of Acute Renal Failure in Liver Transplantation, file e3835311-af04-15e8-e053-a505fe0a3de9
|
17
|
|
Pregnancy after liver transplantation: Report of 8 new cases and review of the literature, file e3835312-050d-15e8-e053-a505fe0a3de9
|
17
|
|
EFFICIENCY OF TRANSGENESIS USING SPERM-MEDIATED GENE TRANSFER :GENERATION OF hDAF TRANSGENIC PIGS, file e3835312-13fc-15e8-e053-a505fe0a3de9
|
17
|
|
HDAF EXPRESSION IN HEARTS OF TRANSGENIC PIGS OBTAINED BY SPERM-MEDIATED GENE TRANSFER, file e3835312-13fe-15e8-e053-a505fe0a3de9
|
17
|
|
Resistive Index and MELD-Na: Nephrologic Monitoring in Cirrhotic Patients Awaiting Liver Transplantation, file e3835312-5987-15e8-e053-a505fe0a3de9
|
16
|
|
A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the Liver Match study, file e3835312-2da6-15e8-e053-a505fe0a3de9
|
15
|
|
Hepatocellular carcinoma in cirrhotic patients: prospective comparison of US, CT and MR imaging, file e3835312-5be4-15e8-e053-a505fe0a3de9
|
14
|
|
Human OX40 tunes the function of regulatory T cells in tumor and nontumor areas of hepatitis C virus-infected liver tissue., file e3835312-6e5b-15e8-e053-a505fe0a3de9
|
14
|
|
ETHICAL CONSIDERATIONS ON KIDNEY TRANSPLANTATION FROM LIVING DONORS, file e3835311-9da2-15e8-e053-a505fe0a3de9
|
13
|
|
Management of sepsis during MARS treatment in acute on chronic liver failure, file e3835311-e8ce-15e8-e053-a505fe0a3de9
|
13
|
|
Combined Liver-Kidney Transplantation in Polycystic Disease: Case Reports, file e3835311-f7e5-15e8-e053-a505fe0a3de9
|
13
|
|
Preoperative Donor Scores and Postoperative Early Measures of Graft Function: Relevance to the Outcome of Liver Transplantation, file e3835311-c639-15e8-e053-a505fe0a3de9
|
12
|
|
MuRF-1 and p-GSK3β expression in muscle atrophy of cirrhosis., file e3835311-fa97-15e8-e053-a505fe0a3de9
|
12
|
|
Pediatric renal transplantation: anesthesia and perioperative complications, file e3835312-1ee1-15e8-e053-a505fe0a3de9
|
12
|
|
SURVIVAL IN KIDNEY TRANSPLANTATION FROM LIVING DONORS: A SINGLE CENTER EXPERIENCE, file e3835312-3cdd-15e8-e053-a505fe0a3de9
|
12
|
|
Liver Transplant Imaging prior to and during the COVID-19 Pandemic, file e383532d-a72e-15e8-e053-a505fe0a3de9
|
12
|
|
Double-blind comparison of hepatitis C histological recurrence Rate in HCV+ Liver transplant recipients given basiliximab + steroids or basiliximab + placebo, in addition to cyclosporine and azathioprine, file e3835311-b6ad-15e8-e053-a505fe0a3de9
|
11
|
|
Long-term effect of liver transplantation on cirrhotic autonomic cardiac dysfunction, file e3835311-dfec-15e8-e053-a505fe0a3de9
|
11
|
|
KIDNEY TRANSPLANTATION FROM LIVING DONORS WITH MULTIPLE RENAL ARTERIES. EXPERIENCES WITH FIBRIN SEALING, file e3835312-0b40-15e8-e053-a505fe0a3de9
|
11
|
|
Human decay accelerating factor transgenic pigs for xenotransplantation obtained by sperm-mediated gene transfer, file e3835312-297d-15e8-e053-a505fe0a3de9
|
10
|
|
A case of portal vein arterialization after a liver transplant, file e383531a-2797-15e8-e053-a505fe0a3de9
|
10
|
|
Multimodal Therapy with Combined Plasmapheresis, Photoapheresis, and Intravenous Immunoglobulin for Acute Antibody-Mediated Renal Transplant Rejection: A 2-Year Follow-up, file e3835311-6e7c-15e8-e053-a505fe0a3de9
|
9
|
|
Conversion From Twice-Daily to Once-Daily Tacrolimus Administration in Liver Transplant Patient, file e3835311-b1fa-15e8-e053-a505fe0a3de9
|
9
|
|
Hepatocellular carcinoma in patients with cirrhosis: qualitative comparison of gadobenate dimeglumine-enhanced MR imaging and multiphasic 64-section CT., file e3835311-def4-15e8-e053-a505fe0a3de9
|
9
|
|
COMPREHENSIVE EVALUATION OF BRAIN DEAD DONORS FOR LIVER TRANSPLANTATION : PERSONAL EXPERIENCE, file e3835312-1392-15e8-e053-a505fe0a3de9
|
9
|
|
MONOETHYLGLYCINEXYLIDIDE CLEARANCE TEST:ITS ROLE AS A PART OF BRAIN DEAD DONORS EVALUATION FOR LIVER TRANSPLANTATION, file e3835312-1396-15e8-e053-a505fe0a3de9
|
9
|
|
Predictive Factors of Outcome After Liver Transplantation in Patients With Cirrhosis and Hepatocellular Carcinoma, file e3835312-20c3-15e8-e053-a505fe0a3de9
|
9
|
|
HEPATIC RESECTION FOR NON COLORECTAL HEPATIC METASTASES, file e3835312-2f89-15e8-e053-a505fe0a3de9
|
9
|
|
ETHICAL CONSIDERATIONS ON KIDNEY TRANSPLANTATION FROM LIVING DONORS, file e3835312-2f91-15e8-e053-a505fe0a3de9
|
9
|
|
Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy, file e3835327-f031-15e8-e053-a505fe0a3de9
|
9
|
|
Proposal and validation of a liver graft discard score for liver transplantation from deceased donors: a multicenter italian study, file e383532f-1e87-15e8-e053-a505fe0a3de9
|
9
|
|
Human duodenal submucosal glands contain a defined stem/progenitor subpopulation with liver-specific regenerative potential, file bf6d23b3-f00d-4f00-abe3-f8edbb48e11c
|
8
|
|
Predictive Factors of Recurrence of Hepatocellular Carcinoma After Liver Transplantation: A Multivariate Analysis, file e3835311-869e-15e8-e053-a505fe0a3de9
|
8
|
|
Balancing Donor and Recipient Risk Factors in Liver
Transplantation: The Value of D-MELD With Particular
Reference to HCV Recipients, file e3835312-0980-15e8-e053-a505fe0a3de9
|
8
|
|
94 CONSECUTIVE LIVING UNRELATED KIDNEY TRANSPLANTS : 8 YEARS GRAFT AND PATIENT SURVIVAL, file e3835312-138f-15e8-e053-a505fe0a3de9
|
8
|
|
Immune-mediated liver dysfunction after antiviral treatment in liver transplanted patients with hepatitis c: Allo or autoimmune de novo hepatitis?, file e3835312-1abe-15e8-e053-a505fe0a3de9
|
8
|
|
Recipient perioperative cholesterolaemia and graft cholesterol metabolism gene expression predict liver transplant outcome, file e3835312-2da5-15e8-e053-a505fe0a3de9
|
8
|
|
SURGICAL TREATMENT OF HEPATIC HEMANGIOMAS: A PERSONAL EXPERIENCE, file e3835312-2f8c-15e8-e053-a505fe0a3de9
|
8
|
|
SURVIVAL IN KIDNEY TRANSPLANTATION FROM LIVING DONORS: A SINGLE CENTER EXPERIENCE, file e3835312-3cde-15e8-e053-a505fe0a3de9
|
8
|
|
Chronic kidney disease after liver transplantation: Pretransplantation risk factors and predictors during follow-up, file e3835312-4149-15e8-e053-a505fe0a3de9
|
8
|
|
MOFETIL MYCOPHENOLATE IN RENAL TRANSPLANTATION, file e3835311-829a-15e8-e053-a505fe0a3de9
|
7
|
|
MULTIPLE ABDOMINAL VISCERAL TRANSPLANTATION: CLINICAL EXPERIENCE OF ORGAN PRESERVATION BY UNIVERSITY OF WISCONSIN (UW) SOLUTION, file e3835311-9ddb-15e8-e053-a505fe0a3de9
|
7
|
|
Graft macrosteatosis and time of T-tube removal as risk factors for biliary strictures after liver transplantation, file e3835311-d06e-15e8-e053-a505fe0a3de9
|
7
|
|
Adacolumn Treatment in Kidney Transplant Patients
With Hepatitis C Virus, file e3835311-f3fd-15e8-e053-a505fe0a3de9
|
7
|
|
Does Caval Reconstruction Technique Affect Early Graft Function after Liver Transplantation? A Preliminary Analysis, file e3835311-fd11-15e8-e053-a505fe0a3de9
|
7
|
|
TRAPIANTO DI FEGATO NELLE DILATAZIONI CONGENITE DELL'ALBERO BILIARE, file e3835312-0df0-15e8-e053-a505fe0a3de9
|
7
|
|
CELSIOR: UNA NUOVA SOLUZIONE EXTRACELLULARE PER LA PERFUSIONE E LA CONSERVAZIONE IPOTERMICA DEGLI ORGANI SOTTODIAFRAMMATICI. ESPERIENZA PERSONALE, file e3835312-0df8-15e8-e053-a505fe0a3de9
|
7
|
|
RENAL TRANSPLANTATION FROM LIVING UNRELATED VS. RELATED KIDNEY DONORS, file e3835312-2f8d-15e8-e053-a505fe0a3de9
|
7
|
|
Uncommon indications for associating liver partition and portal vein ligation for staged hepatectomy: a systematic review, file f27a85bc-0c3e-4db7-959f-3e9d2d95f087
|
7
|
|
GIANT HEMANGIOMAS OF THE LIVER: SURGICAL STRATEGIES AND TECHNICAL ASPECTS, file e3835311-68a6-15e8-e053-a505fe0a3de9
|
6
|
|
MULTIPLE ORGAN HARVESTING: EVOLUTION OF SURGICAL TECHNIQUE. PERSONAL EXPERIENCE, file e3835311-7b58-15e8-e053-a505fe0a3de9
|
6
|
|
Incidence of fungal infections in a solid organ recipients dedicated intensive care unit, file e3835311-9c37-15e8-e053-a505fe0a3de9
|
6
|
|
LIVING UNRELATED KIDNEY TRANSPLANTATION: A 12-YEAR SINGLE CENTER EXPERIENCE, file e3835311-a143-15e8-e053-a505fe0a3de9
|
6
|
|
Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation, file e3835311-c554-15e8-e053-a505fe0a3de9
|
6
|
|
Fertility following solid organ transplantation, file e3835311-c7a3-15e8-e053-a505fe0a3de9
|
6
|
|
Impact of Anti-Hepatitis B Core-Positive Donors in Liver Transplantation: A Survival Analysis, file e3835311-e206-15e8-e053-a505fe0a3de9
|
6
|
|
Model for End-stage Liver Disease Score versus Simplified Acute Physiology Score Criteria in Acute Renal Failure After Liver Transplantation, file e3835311-fd10-15e8-e053-a505fe0a3de9
|
6
|
|
IS UNRELATED LIVING DONOR A VALID ORGAN SOURCE IN RENAL TRANSPLANTATION UNDER CyA THERAPY?, file e3835312-130e-15e8-e053-a505fe0a3de9
|
6
|
|
NON SPECIFIC CHOLESTATIC SYNDROME IN LIVER TRANSPLANTATION: SUCCESSFUL SYMPTOMATIC TREATMENT BY PLASMA EXCHANGE, file e3835312-1390-15e8-e053-a505fe0a3de9
|
6
|
|
LIVING UNRELATED KIDNEY TRANSPLANTATION DONOR: A VALID AND SAFE SOURCE, file e3835312-300b-15e8-e053-a505fe0a3de9
|
6
|
|
From Listing to Transplant: Nephrologic Monitoring in Cirrhotic Patients Awaiting Liver Transplantation, file e3835312-5914-15e8-e053-a505fe0a3de9
|
6
|
| Totale |
3772 |